Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Completed

Conditions studied: Chronic Lymphocytic Leukemia

In brief

The purpose of the Connect™ Chronic Lymphocytic Leukemia (CLL) Disease Registry is to explore the history and real world management of patients diagnosed with CLL, provide insight into the management of CLL, and evaluate the effectiveness of first, second and subsequent therapeutic strategies employed in both the community and academic settings.

Key facts

Study ID

NCT01081015

Run by

Celgene

People needed

1494

Starts

2010-03-19

Expected to finish

2017-12-31

Last updated by the study team

2020-05-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis with CLL
• Clinical decision made to initiate first-line therapy, second-line therapy or subsequent line of therapy prior to enrollment into the ConnectTM CLL registry, but within 2 months of enrollment
• Age≥18 years
• Willing and able to provide signed informed consent
• Willing and able to complete patient assessment questionnaires either alone or with minimal assistance from caregivers and/or trained site personnel

You may not qualify if…

• Participation in a clinical study in which study treatment is blinded
• Patient condition is considered terminal (i.e.<6 months to live)

Where it is running

• Medical Specialists of the Palm Beaches — Atlantis, Florida, United States
• University Cancer Institute — Boynton Beach, Florida, United States
• Thomas Niederman, MD — Boynton Beach, Florida, United States
• Pasco Hernando Oncology Associates (Kumar) — New Port Richey, Florida, United States
• Phoebe Putney Memorial Hospital — Albany, Georgia, United States
• Peachtree Hematology-Oncology Consultants — Atlanta, Georgia, United States
• Georgia Cancer Specialists — Atlanta, Georgia, United States
• US Oncology - Dublin Hematology & Oncology — Dublin, Georgia, United States
• Straub Clinic and Hospital — Honolulu, Hawaii, United States
• US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Arlington — Arlington Heights, Illinois, United States
• John H. Stroger, Jr., Hospital of Cook County — Chicago, Illinois, United States
• Rush University Medical Center — Chicago, Illinois, United States
• Ingalls Cancer Research Center — Harvey, Illinois, United States
• Elmhurst Memorial Hospital — Lombard, Illinois, United States
• Oncology Specialists, S.C. — Niles, Illinois, United States
• US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles — Niles, Illinois, United States
• Illinois Cancer Care — Peoria, Illinois, United States
• Orchard Research — Skokie, Illinois, United States
• Carle Cancer Center — Urbana, Illinois, United States
• US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Winfield — Winfield, Illinois, United States
• St. Francis Cancer Research — Beech Grove, Indiana, United States
• Center for Cancer Care @ Goshen Health Systems — Goshen, Indiana, United States
• Indiana University Cancer Center Clinical Research Office — Indianapolis, Indiana, United States
• Cancer Care Partners, LLC — Mishawaka, Indiana, United States
• New Hope Cancer & Research Institute — Pomona, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.